eccogene glp 1 Enters Exclusive License Agreement With AstraZeneca to Develop and Commercialize Small Molecule GLP-1 Receptor Agonist ECC5004 for Cardiometabolic Diseases AZD5004

These injectable medications mimic a natural hormone called glucagon-like peptide-1 (GLP-1), which helps regulate your appetite, blood sugar levels, and digestion

Many clients receive injections weekly as part of a weight loss or wellness program, but we can tailor a schedule to meet your needs

Concentration is not the same as quality, and the highest number on the label is rarely the best purchase

doi: 10.1042/CS20060103 95 Berlanga-AcostaJCibrianDValiente-MustelierJSurez-AlbaJGarca-OjalvoAFalcn-CamaVet al

Human pilot evidence Three small pilots: a 12-patient knee-pain case series (Lee & Padgett, Alternative Therapies in Health and Medicine, 2021)